2024
Early Tibial Vessel Recoil Following Treatment With the Bare Temporary Spur Stent System: Results From the DEEPER OUS Vessel Recoil Substudy.
Zeller T, Zhang Z, Parise H, Mascho C, Holden A, Schmidt A, Thieme M, Piorkowski M, Hertting K, Wissgott C, Andrassy M, Noory E, Weinberg I, Kolluri R. Early Tibial Vessel Recoil Following Treatment With the Bare Temporary Spur Stent System: Results From the DEEPER OUS Vessel Recoil Substudy. Journal Of Endovascular Therapy 2024, 15266028241280685. PMID: 39305087, DOI: 10.1177/15266028241280685.Peer-Reviewed Original ResearchMinimal lumen diameterMinutes post-treatmentBalloon angioplastyTreated lesion lengthVessel recoilLumen diameterLesion lengthVessel preparation strategyNo significant differenceStatistically significant correlationDuplex ultrasoundPost-treatmentLesion characteristicsTherapy supplementsPatencyLesionsPatientsVessel preparationStent systemSignificant differenceTibial diseaseAntiproliferative drugsMonthsTherapyAngioplasty
2023
Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication
Altin S, Parise H, Hess C, Rosenthal N, Creager M, Aronow H, Curtis J. Long-Term Patient Outcomes After Femoropopliteal Peripheral Vascular Intervention in Patients With Intermittent Claudication. JACC Cardiovascular Interventions 2023, 16: 1668-1678. PMID: 37438035, DOI: 10.1016/j.jcin.2023.05.001.Peer-Reviewed Original ResearchConceptsPeripheral vascular interventionsIndex limb amputationAmputation rateIntermittent claudicationMajor amputationRevascularization ratesVascular interventionsCox proportional hazards regressionLong-term patient outcomesMajor amputation rateProportional hazards regressionKaplan-Meier estimatesFurther risk factorsLimb amputation rateClinical trial dataIndex limbIC patientsSecondary outcomesPrimary outcomeHazards regressionRisk factorsPatient outcomesLimb amputationHealthcare databasesPatientsImpact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study
See C, Wang Y, Huang H, Parise H, Yang Y, Tirziu D, Francese D, Papoutsidakis N, Bader E, Kaple R, Cleman M, Lansky A, Forrest J. Impact of New‐Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single‐Center Study. Journal Of Interventional Cardiology 2023, 2023: 5390338. PMID: 37292113, PMCID: PMC10247319, DOI: 10.1155/2023/5390338.Peer-Reviewed Original ResearchConceptsTranscatheter aortic valve replacementNew-onset conduction disturbancesAortic valve replacementPersistent conduction disturbancesConduction disturbancesValve replacementSurgical aortic valve replacementSingle-center retrospective analysisYale-New Haven HospitalSingle-center studyCause mortality ratesCause mortality riskLong-term outcomesNew Haven HospitalPeriprocedural factorsAortic stenosisConsecutive patientsTAVR proceduresTerm outcomesRetrospective analysisMortality riskMortality ratePatientsOutcomesPatient's ECG
2022
Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation
Persu A, Maes F, Toennes S, Ritscher S, Georges C, Wallemacq P, Haratani N, Parise H, Fischell T, Lauder L, Mahfoud F. Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation. Blood Pressure 2022, 31: 109-117. PMID: 35575248, DOI: 10.1080/08037051.2022.2074367.Peer-Reviewed Original ResearchConceptsRenal denervationDrug adherenceBlood pressure changesNon-adherent patientsPoor drug adherenceTreatment-resistant hypertensionSham-controlled trialBlood pressure responseSystolic blood pressureUncontrolled hypertensionAntihypertensive medicationsResistant hypertensionSuch patientsBlood pressureAntihypertensive drugsDenervationMean 24Partial adherencePatientsFull adherenceUrinary detectionHypertensionPressure changesLiquid chromatography-tandem mass spectrometryAdherence
2020
Evaluation of Transcatheter Alcohol-Mediated Perivascular Renal Denervation to Treat Resistant Hypertension
Janas A, Król M, Hochuł M, Jochymczyk M, Hayward-Costa C, Parise H, Haratani N, Fischell T, Wojakowski W. Evaluation of Transcatheter Alcohol-Mediated Perivascular Renal Denervation to Treat Resistant Hypertension. Journal Of Clinical Medicine 2020, 9: 1881. PMID: 32560164, PMCID: PMC7356226, DOI: 10.3390/jcm9061881.Peer-Reviewed Original ResearchAmbulatory blood pressure monitoringRenal denervationResistant hypertensionOffice BPCatheter-based renal denervationBlood pressure monitoringRenal artery anatomyHypothesis-generating studyContrast computer tomographyAnti-hypertension drugsNephrologist consultationResistant HTNAdult patientsSympathetic nervesSystolic pressureHypertension treatmentRenal arteryArtery anatomyAdventitial spaceMean decreasePressure monitoringPatientsDenervationHypertensionVariable success
2019
IN-HOSPITAL OUTCOMES AFTER TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE 2012-2015 NATIONAL INPATIENT SAMPLE
Panchal H, Stone G, Parise H, Davidson C, Leon M, Nagabandi A, Beohar N. IN-HOSPITAL OUTCOMES AFTER TRANSCATHETER EDGE-TO-EDGE MITRAL VALVE REPAIR IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE 2012-2015 NATIONAL INPATIENT SAMPLE. Journal Of The American College Of Cardiology 2019, 73: 1180. DOI: 10.1016/s0735-1097(19)31787-5.Peer-Reviewed Original Research
2014
Clinical and Angiographic Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent in Japanese Patients
Saito S, Maehara A, Vlachojannis G, Parise H, Mehran R. Clinical and Angiographic Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent in Japanese Patients. Circulation Journal 2014, 79: 96. PMID: 25428602, DOI: 10.1253/circj.cj-14-0836.Peer-Reviewed Original ResearchMeSH KeywordsCombined Modality TherapyCoronary AngiographyCoronary RestenosisCoronary StenosisDrug-Eluting StentsHeart DiseasesHumansIncidenceJapanMyocardial InfarctionMyocardial RevascularizationNeointimaPlatelet Aggregation InhibitorsPostoperative ComplicationsProspective StudiesRisk FactorsSirolimusTreatment OutcomeUltrasonography, InterventionalConceptsTarget lesion revascularizationJapanese patientsR-ZESDe novo native coronary lesionsIncidence of TLRSingle-arm observational studyStent late lumen lossLong-term clinical outcomesNative coronary lesionsTarget lesion failureLate lumen lossLesion revascularizationResolute ZotarolimusLesion failureVolume obstructionAngiographic evaluationClinical outcomesCoronary lesionsLumen lossObservational studyNeointimal hyperplasiaIntravascular ultrasoundPatientsVessel studiesCoronary stentsBIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALS
Steg P, Mehran R, Goldstein P, Witzenbichler B, Hof A, Guagliumi G, Hamm C, Genereux P, Clemmensen P, Parise H, Pocock S, Gersh B, Bernstein D, Deliargyris E, Stone G, Bichat H. BIVALIRUDIN VERSUS HEPARIN WITH OR WITHOUT GLYCOPROTEIN IIB/IIIA INHIBITORS IN STEMI PATIENTS UNDERGOING PRIMARY PCI: A POOLED ANALYSIS OF PATIENT-LEVEL DATA FROM THE HORIZONS-AMI AND EUROMAX TRIALS. Journal Of The American College Of Cardiology 2014, 63: a34. DOI: 10.1016/s0735-1097(14)60034-6.Peer-Reviewed Original Research
2013
Impact of Scheduled Angiographic Follow‐Up in Patients Treated With Primary Percutaneous Coronary Intervention for ST‐Segment Elevation Myocardial Infarction
MINDRESCU C, BRENER S, GUERCHICOFF A, FAHY M, PARISE H, MEHRAN R, STONE G. Impact of Scheduled Angiographic Follow‐Up in Patients Treated With Primary Percutaneous Coronary Intervention for ST‐Segment Elevation Myocardial Infarction. Journal Of Interventional Cardiology 2013, 26: 319-324. PMID: 23795656, DOI: 10.1111/joic.12038.Peer-Reviewed Original ResearchConceptsST-segment elevation myocardial infarctionTarget vessel revascularizationPercutaneous coronary interventionPrimary percutaneous coronary interventionElevation myocardial infarctionMyocardial infarctionCoronary interventionStent thrombosisAcute Myocardial Infarction trialMyocardial Infarction trialOutcomes of patientsRate of revascularizationAngiographic Follow-upSAF groupRate of deathHarmonizing OutcomesVessel revascularizationCerebral eventsMI ratesFollow-upPatientsRevascularizationInfarctionComposite rateDeathLACK OF ASSOCIATION BETWEEN ON–TREATMENT PLATELET REACTIVITY AND ISCHEMIC OUTCOMES IN DIABETIC PATIENTS: ONE YEAR RESULTS OF THE ADAPT–DES STUDY
Stuckey T, Kirtane A, Xu K, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger C, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Cristea E, Parise H, Mehran R, Stone G. LACK OF ASSOCIATION BETWEEN ON–TREATMENT PLATELET REACTIVITY AND ISCHEMIC OUTCOMES IN DIABETIC PATIENTS: ONE YEAR RESULTS OF THE ADAPT–DES STUDY. Journal Of The American College Of Cardiology 2013, 61: e1737. DOI: 10.1016/s0735-1097(13)61737-4.Peer-Reviewed Original ResearchIMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDY
Rinaldi M, Kirtane A, Xu K, Witzenbichler B, Weisz G, Neumann F, Metzger C, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Cristea E, Parise H, Mehran R, Stone G. IMPACT OF POINT–OF–CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG–ELUTING STENTS: AN ADAPT–DES SUBSTUDY. Journal Of The American College Of Cardiology 2013, 61: e1857. DOI: 10.1016/s0735-1097(13)61857-4.Peer-Reviewed Original Research
2012
IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY
Kirtane A, Stuckey T, Parise H, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Mazzaferri E, Cristea E, Mehran R, Stone G. IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG DIABETIC AND NON-DIABETIC PATIENTS UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY. Journal Of The American College Of Cardiology 2012, 59: e268. DOI: 10.1016/s0735-1097(12)60269-1.Peer-Reviewed Original ResearchIMPACT OF BIVALIRUDIN AND PACLITAXEL-ELUTING STENTS IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI OF THE LEFT ANTERIOR DESCENDING ARTERY: THE HORIZONS-AMI TRIAL
Woehrle J, Parise H, Mehran R, Stone G. IMPACT OF BIVALIRUDIN AND PACLITAXEL-ELUTING STENTS IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI OF THE LEFT ANTERIOR DESCENDING ARTERY: THE HORIZONS-AMI TRIAL. Journal Of The American College Of Cardiology 2012, 59: e280. DOI: 10.1016/s0735-1097(12)60281-2.Peer-Reviewed Original ResearchDOES PLATELET FUNCTION TESTING ADD SIGNIFICANT INCREMENTAL RISK STRATIFICATION TO UNSELECTED PATIENTS UNDERGOING DES IMPLANTATION? THE ADAPT-DES STUDY
Kirtane A, Parise H, Witzenbichler B, Weisz G, Rinaldi M, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Cristea E, Mehran R, Stone G. DOES PLATELET FUNCTION TESTING ADD SIGNIFICANT INCREMENTAL RISK STRATIFICATION TO UNSELECTED PATIENTS UNDERGOING DES IMPLANTATION? THE ADAPT-DES STUDY. Journal Of The American College Of Cardiology 2012, 59: e292. DOI: 10.1016/s0735-1097(12)60293-9.Peer-Reviewed Original ResearchIMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY
Kirtane A, Rinaldi M, Parise H, Witzenbichler B, Weisz G, Neumann F, Metzger D, Henry T, Cox D, Duffy P, Brodie B, Stuckey T, Mazzaferri E, Cristea E, Mehran R, Stone G. IMPACT OF POINT-OF-CARE PLATELET FUNCTION TESTING AMONG PATIENTS WITH AND WITHOUT ACUTE CORONARY SYNDROMES UNDERGOING PCI WITH DRUG-ELUTING STENTS: AN ADAPT-DES SUBSTUDY. Journal Of The American College Of Cardiology 2012, 59: e291. DOI: 10.1016/s0735-1097(12)60292-7.Peer-Reviewed Original Research
2011
IMPACT OF BIVALIRUDIN PROCEDURAL ANTICOAGULATION IN PATIENTS WITH DIABETES MELLITUS AND ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: 3-YEAR RESULTS FROM THE HORIZONS AMI TRIAL
Witzenbichler B, Mehran R, Guagliumi G, Desaga M, Kochman J, Nilsen D, Finkelstein A, Mosseri M, Parise H, Cristea E, Stone G. IMPACT OF BIVALIRUDIN PROCEDURAL ANTICOAGULATION IN PATIENTS WITH DIABETES MELLITUS AND ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: 3-YEAR RESULTS FROM THE HORIZONS AMI TRIAL. Journal Of The American College Of Cardiology 2011, 57: e1801. DOI: 10.1016/s0735-1097(11)61801-9.Peer-Reviewed Original ResearchDISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI
Mehran R, Claessen B, Dangas G, Suh J, Parise H, Lansky A, Witzenbichler B, Grines C, Guagliumi G, Kornowski R, Wöhrle J, Dudek D, Weisz G, Moses J, Stone G. DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI. Journal Of The American College Of Cardiology 2011, 57: e1785. DOI: 10.1016/s0735-1097(11)61785-3.Peer-Reviewed Original Research
2010
IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL
Witzenbichler B, Woehrle J, Guagliumi G, Peruga J, Brodie B, Dudek D, Kornowski R, Hartmann F, Parise H, Lansky A, Nikolsky E, Mehran R, Stone G. IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL. Journal Of The American College Of Cardiology 2010, 55: a182.e1708. DOI: 10.1016/s0735-1097(10)61709-3.Peer-Reviewed Original Research